#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15292	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2192	694.4	0	.	n	.	0	C207T	SNP	207	207	C	533	533	T	845	T,C	384,397	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15292	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2192	694.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1776	1776	T	786	T,C	734,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15292	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2192	694.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1510	1510	C	902	C	833	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15292	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2192	694.4	0	HET	.	.	.	A69G	.	69	69	A	395	395	A	878	A,G	448,360	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27960	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3638	766.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1676	1676	A	916	A	853	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27960	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3638	766.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2310	2310	C	901	C,T	839,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27960	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3638	766.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2384	2384	A	861	A	805	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27960	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3638	766.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2936	2936	C	861	C,T	814,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	2084	folP	852	852	99.88	folP.l6.c4.ctg.1	1586	130.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	870	872	AAA	194;195;195	A,G;A;A	184,1;187;185	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	2084	folP	852	852	99.88	folP.l6.c4.ctg.1	1586	130.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1101	1103	AGC	192;193;193	A;G;C	179;179;173	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5552	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3426	161.4	1	SNP	p	S91F	0	.	.	271	273	TCC	726	728	TCC	196;200;200	T;C;C	182;183;185	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5552	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3426	161.4	1	SNP	p	D95G	0	.	.	283	285	GAC	738	740	GAC	203;203;204	G;A;C	185;182;188	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5552	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3426	161.4	1	SNP	p	D95N	0	.	.	283	285	GAC	738	740	GAC	203;203;204	G;A;C	185;182;188	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1732	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1388	124.3	1	SNP	p	G45D	0	.	.	133	135	GGC	555	557	GGC	240;239;243	G;G;C	229;229;233	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	816	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	989	82.0	0	.	n	.	0	A197.	DEL	197	197	A	645	645	A	203	A	192	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5508	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2911	188.4	1	SNP	p	D86N	0	.	.	256	258	GAC	586	588	GAC	228;228;229	G;A;C	206;205;210	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5508	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2911	188.4	1	SNP	p	S87I	0	.	.	259	261	AGT	589	591	AGT	231;237;237	A;G;T	213;217;214	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5508	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2911	188.4	1	SNP	p	S87W	0	.	.	259	261	AGT	589	591	AGT	231;237;237	A;G;T	213;217;214	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5508	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2911	188.4	1	SNP	p	S87R	0	.	.	259	261	AGT	589	591	AGT	231;237;237	A;G;T	213;217;214	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5508	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2911	188.4	1	SNP	p	S88P	0	.	.	262	264	TCC	592	594	TCC	237;241;241	T;C;C	214;219;219	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4414	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2666	165.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1526	1528	GGC	213;211;211	G;G;C	197;188;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1299	1301	GCA	213;216;217	G;C,G;A	196;197,1;199	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1302	1304	ATC	218;218;219	A;T;C	200;199;200	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1314	1316	GTG	226;228;227	G;T;G,T	206;206;206,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1314	1316	GTG	226;228;227	G;T;G,T	206;206;206,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1818	1820	ACC	224;220;222	A;C;C,T	208;210;211,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1872	1874	GCG	210;214;217	G;C,G;G	188;171,1;184	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1872	1874	GCG	210;214;217	G;C,G;G	188;171,1;184	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1995	1997	GGC	201;200;193	G;G;C	179;179;177	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2004	2006	GGC	187;186;186	G;G;C	174;169;167	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4200	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2486	168.3	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2022	2024	CTG	176;177;178	C,G;T;G	141,2;138;144	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5960	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3113	190.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1628	1630	CCG	226;227;230	C;C;G	199;206;205	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2306	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1977	116.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	158	C	147	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	351	353	GAA	253;253;256	G;A;A	236;238;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	639	641	GAT	235;237;238	G;A;T	213;215;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	762	764	TCA	266;266;266	T;C;A	246;247;247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	891	893	GTC	228;223;223	G,A;T;C	210,1;203;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	903	905	TCT	216;216;217	T;C,T;T	200;200,1;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1221	1223	GCA	221;220;220	G;C;A	203;200;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	1	SNP	p	G120K	1	.	.	358	360	AAG	597	599	AAG	228;227;230	A;A;G	209;208;214	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	1	SNP	p	D121N	0	.	.	361	363	GAC	600	602	GAC	233;231;230	G;A;C	217;214;215	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2804	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1431	194.1	1	SNP	p	A121D	1	.	.	361	363	GAC	600	602	GAC	233;231;230	G;A;C	217;214;215	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10678	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4942	215.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2066	2068	AAT	231;233;235	A;A;T	214;218;217	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1080	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1242	86.7	1	SNP	p	V57M	1	.	.	169	171	ATG	656	658	ATG	217;217;219	A,G;T;G	202,1;203;201	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
